預測性基因檢測資訊作為保險核保因子法政策之再思考【本期企劃】 試閱
Rethinking the Issue of Allowing the Use of Predictive Genetic Testing Results in Insurance Underwriting
近年,預測性基因檢測之成本驟降使其普及性提高,亦使基因檢測資訊得否作為保險核保因子之議論再起。本文首擬藉探討基因檢測技術之進步對保險業帶來之契機,確立預測性基因檢測資訊作為保險核保因子命題討論之迫切性,再以辯證法就反對與贊成保險人使用基因檢測資訊之論點一一探討,並加以評析回應,復以英國法例,提出此一命題立法實踐之走向,最末對臺灣現行法制如何導入此一命題,提出建言。
In recent years, the lowering costs of predictive genetic testing has facilitated its prevailing and again raise the issue: Whether predictive genetic test results should be permitted to use in insurance underwriting. This note first explores the opportunity the progress of genetic testing technology brings to the insurance industry so as to verify the urgency of discussing the above issue. Second, dialectic approach will be applied to analyze and respond to both pros and cons regarding insurers’ utilization of genetic testing result. Third, British model will be introduced and proclaimed as a model which best balance the interests of consumers and insurers. Last, based on the dialectic analyses and British model, this note will answer the question: How Taiwanese Law should reflect on this issue.
020-033